“…The role of the endocannabinoid system in fear responding per se (i.e. in the absence of nociceptive tone) has been examined extensively and the weight of evidence suggests that endocannabinoid-CB 1 receptor signalling serves to facilitate and enhance the extinction of conditioned fear responding (for review see [15,48,79]), while genetic deletion or pharmacological blockade of the CB 1 receptor attenuates short-and long-term extinction of conditioned fear responding [14,18,25,39,44,48,52,59,62,70,76]. The results of the present study, however, suggest that in the presence of formalin-evoked nociceptive tone, increased endocannabinoid signalling in the vHip (as a consequence of URB597 administration) in fact serves to inhibit rather than enhance the short-term, within-trial extinction of fear responding.…”